Protein-losing enteropathy and the Fontan operation

Nutrition in Clinical Practice

Volumn 27, Issue 3, 2012, Pages 375-384

  Johnson, Jonathan N ^a   Driscoll, David J ^a   O'Leary, Patrick W ^a  

^a Mayo Clinic   (United States)

Author keywords

Fontan procedure; protein losing enteropathies

Indexed keywords

ALPHA 1 ANTITRYPSIN; BRAIN NATRIURETIC PEPTIDE; BUDESONIDE; FUROSEMIDE; GAMMA INTERFERON; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; OCTREOTIDE; PREDNISONE; SILDENAFIL; SPIRONOLACTONE; TUMOR NECROSIS FACTOR;

ADRENAL SUPPRESSION; ASCITES; BASEMENT MEMBRANE; BLEEDING; BLOATING; BLOOD CLOTTING DISORDER; CARDIOVASCULAR MALFORMATION; CELL DEGENERATION; CENTRAL VENOUS PRESSURE; CHOLELITHIASIS; CYANOSIS; DIARRHEA; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EDEMA; ELECTROLYTE DISTURBANCE; FONTAN PROCEDURE; FORWARD HEART FAILURE; GYNECOMASTIA; HEART ARRHYTHMIA; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOKALEMIA; HYPOPROTEINEMIA; HYPOTENSION; IMMUNOGLOBULIN DEFICIENCY; IN VITRO STUDY; INTESTINE LYMPHANGIECTASIA; INVASIVE PROCEDURE; LIVER TOXICITY; LYMPHOCYTOPENIA; MALNUTRITION; MORBIDITY; MORTALITY; OSTEOPENIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIAPISM; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; SIDE EFFECT; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROTEIN-LOSING ENTEROPATHIES; RISK FACTORS;

EID: 84861817566     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612444532     Document Type: Review

References (46)

1. Davidson JD, Waldmann TA, Goodman DS, Gordon RS. Protein-losing gastroenteropathy in congestive heart-failure. Lancet. 1961 ; 1: 899-902
2. Moodie DS, Feldt RH, Wallace RB. Transient protein-losing enteropathy secondary to elevated caval pressures and caval obstruction after the Mustard procedure. J Thorac Cardiovasc Surg. 1976 ; 72: 379-382
3. Gleason WA, Roodman ST, Laks H. Protein-losing enteropathy and intestinal lymphangiectasia after superior vena cava-right pulmonary artery (Glenn) shunt. J Thorac Cardiovasc Surg. 1979 ; 77: 843-846
4. Crupi G, Locatelli G, Tiraboschi R, Villani M, De Tommasi M, Parenzan L. Protein-losing enteropathy after Fontan operation for tricuspid atresia (imperforate tricuspid valve). Thorac Cardiovasc Surg. 1980 ; 28: 359-363
5. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971 ; 26: 240-248
6. Driscoll DJ. Long-term results of the Fontan operation. Pediatr Cardiol. 2007 ; 28: 438-442
7. Beghetti M. Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies. Heart. 2010 ; 96: 911-916
8. Goldberg DJ, Dodds K, Rychik J. Rare problems associated with the Fontan circulation. Cardiol Young. 2010 ; 20 (suppl 3). 113-119
9. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis. 2007 ; 2: 288-300
10. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg. 1998 ; 115: 1063-1073
11. Rychik J, Gui-Yang S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am J Cardiol. 2002 ; 90: 672-674
12. Shimizu T, Nagata S, Fujii T, et al. Enhanced production of interferon-gamma as a possible cause of protein-losing enteropathy after modified Fontan operation. J Pediatr Gastroenterol Nutr. 2003 ; 37: 504-507
13. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg. 2006 ; 82: 695-700
14. Bode L, Eklund EA, Murch S, Freeze HH. Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy. Am J Physiol Gastrointest Liver Physiol. 2005 ; 288: G1015 - G1023
15. Bode L, Murch S, Freeze HH. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem. 2006 ; 281: 7809-7815
16. Ohhashi T, Watanabe N, Kawai Y. Effects of atrial natriuretic peptide on isolated bovine mesenteric lymph vessels. Am J Physiol. 1990 ; 259: H42 - H27
17. Westphal V, Murch S, Kim S, et al. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. Am J Pathol. 2000 ; 157: 1917-1925
18. Feldt RH, Driscoll DJ, Offord KP, et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 1996 ; 112: 672-680
19. Thorne SA, Hooper J, Kemp M, Somerville J. Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease. Eur Heart J. 1998 ; 19: 514-520
20. Amaral FT, Atik E. Protein-losing enteropathy after the Fontan operation. Arq Bras Cardiol. 2006 ; 87: e156 - e161
21. Florent C, L'Hirondel C, Desmazures C, Aymes C, Bernier JJ. Intestinal clearance of alpha 1-antitrypsin: a sensitive method for the detection of protein-losing enteropathy. Gastroenterology. 1981 ; 81: 777-780
22. Fujii T, Shimizu T, Takahashi K, et al. Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations. J Pediatr Gastroenterol Nutr. 2003 ; 37: 577-580
23. Silvilairat S, Cabalka AK, Cetta F, Grogan M, Hagler DJ, O'Leary PW. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome. Congenit Heart Dis. 2008 ; 3: 262-268
24. Menon S, Hagler D, Cetta F, Gloviczki P, Driscoll D. Role of caval venous manipulation in treatment of protein-losing enteropathy. Cardiol Young. 2008 ; 18: 275-281
25. Cohen MI, Bush DM, Ferry RJ, et al. Somatic growth failure after the Fontan operation. Cardiol Young. 2000 ; 10: 447-457
26. Ringel RE, Peddy SB. Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am J Cardiol. 2003 ; 91: 1031-1032
27. Senzaki H, Masutani S, Kobayashi J, et al. Ventricular afterload and ventricular work in Fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with blalock-taussig shunts. Circulation. 2002 ; 105: 2885-2892
28. Khambadkone S, Li J, de Leval MR, Cullen S, Deanfield JE, Redington AN. Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation. 2003 ; 107: 3204-3208
29. Goldberg DJ, French B, McBride MG, et al. Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation. 2011 ; 123: 1185-1193
30. Schuuring MJ, Vis JC, Bouma BJ, et al. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?. Contemp Clin Trials. 2011 ; 32: 586-591
31. Rothman A, Snyder J. Protein-losing enteropathy following the Fontan operation: resolution with prednisone therapy. Am Heart J. 1991 ; 121: 618-619
32. Rychik J, Piccoli DA, Barber G. Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am J Cardiol. 1991 ; 68: 819-821
33. Thacker D, Patel A, Dodds K, Goldberg DJ, Semeao E, Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg. 2010 ; 89: 837-842
34. John AS, Driscoll DJ, Warnes CA, Phillips SD, Cetta F. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation. Ann Thorac Surg. 2011 ; 92: 1451-1456
35. Donnelly JP, Rosenthal A, Castle VP, Holmes RD. Reversal of protein- losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J Pediatr. 1997 ; 130: 474-478
36. Jahangiri M, Ross DB, Redington AN, Lincoln C, Shinebourne EA. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg. 1994 ; 58: 1409-1413
37. John AS, Phillips SD, Driscoll DJ, Warnes CA, Cetta F. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation. Congenit Heart Dis. 2011 ; 6: 653-656
38. Vyas H, Driscoll DJ, Cabalka AK, Cetta F, Hagler DJ. Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv. 2007 ; 69: 584-589
39. Mertens L, Dumoulin M, Gewillig M. Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation. Br Heart J. 1994 ; 72: 591-592
40. Cohen MI, Rhodes LA, Wernovsky G, Gaynor JW, Spray TL, Rychik J. Atrial pacing: an alternative treatment for protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 2001 ; 121: 582-583
41. de Leval MR, Dubini G, Migliavacca F, et al. Use of computational fluid dynamics in the design of surgical procedures: application to the study of competitive flows in cavo-pulmonary connections. J Thorac Cardiovasc Surg. 1996 ; 111: 502-513
42. Sheikh AM, Tang AT, Roman K, et al. The failing Fontan circulation: successful conversion of atriopulmonary connections. J Thorac Cardiovasc Surg. 2004 ; 128: 60-66
43. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006 ; 114: 273-280
44. Kanter KR, Mahle WT, Vincent RN, Berg AM, Kogon BE, Kirshbom PM. Heart transplantation in children with a Fontan procedure. Ann Thorac Surg. 2011 ; 91: 823-829
45. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, et al. Cardiac transplantation after the Fontan or Glenn procedure. J Am Coll Cardiol. 2004 ; 44: 2065-2072
46. Bhagirath KM, Tam JW. Resolution of protein-losing enteropathy with low-molecular weight heparin in an adult patient with Fontan palliation. Ann Thorac Surg. 2007 ; 84: 2110-2112